[1. Stucky CC, Johnson KN, Gray RJ, Stucky CC, Johnson KN, Gray RJ, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 2012; 19: 878-85.10.1245/s10434-011-1978-721861229]Search in Google Scholar
[2. Van Herendael BH, Heyman SR, Vanhoenacker FM, De Temmerman G, Bloem JL, Parizel PM, et al. The value of magnetic resonance imaging in the differentiation between malignant peripheral nerve-sheath tumors and non-neurogenic malignant soft-tissue tumors. Skeletal Radiol 2006; 35: 745-53.10.1007/s00256-006-0160-y16775712]Search in Google Scholar
[3. Ramanathan RC, Thomas JM. Malignant peripheral nerve sheath tumours associated with von Recklinghausen’s neurofibromatosis. Eur J Surg Oncol 1999; 25: 190-3.10.1053/ejso.1998.062510218464]Search in Google Scholar
[4. Shimizu J, Arano Y, Murata T, Ishikawa N, Yachi T, Nomura T, et al. A case of intrathoracic giant malignant peripheral nerve sheath tumor in neurofibromatosis type I (von Recklinghausen’s disease). Ann Thorac CardiovascSurg 2008; 14: 42-7.]Search in Google Scholar
[5. Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer 2006; 107: 1065-74.10.1002/cncr.2209816881077]Search in Google Scholar
[6. McConnell YJ, Giacomantonio CA. Malignant triton tumors-complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol 2012; 106: 51-6.10.1002/jso.2304222253011]Search in Google Scholar
[7. Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, et al. Malignant peripheral nerve sheath tumors: Prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Eur J Surg Oncol 2013; 39: 46-52.10.1016/j.ejso.2012.09.00123084090]Search in Google Scholar
[8. Kim JG, Sung WJ, Kim DH, Kim YH, Sohn SK, Lee KB. Malignant peripheral nerve sheath tumor in neurofibromatosis type I: unusual presentation of intraabdominal or intrathoracic mass. Korean J Intern Med 2005; 20: 100-4.10.3904/kjim.2005.20.1.100389140515906964]Search in Google Scholar
[9. Chu YC, Yoon YH, Han HS, Han JY, Kim JM, Park IS. Malignant transformation of intrathoracic ancient neurilemmoma in a patient without von Recklinghausen’s disease. J Korean Med Sci 2003; 18: 295-8.10.3346/jkms.2003.18.2.295305503412692434]Search in Google Scholar
[10. McLaughlin EJ, Heuer GG, Whitmore RG, Birknes JK, Belasco J, Sterman D, et al. Treatment of a malignant peripheral nerve sheath tumor and its complications through a multidisciplinary approach. J Neurosurg Pediatr 2011; 7: 543-8.10.3171/2011.2.PEDS117521529197]Search in Google Scholar
[11. Patel VS, St Louis JD, Oduntan O, Landolfo KP. Intrathoracic peripheral nerve sheath tumors in patients with neurofibromatosis type 1 (von Recklinghausen disease). J Thorac Cardiovasc Surg 2006; 131: 736-7.10.1016/j.jtcvs.2005.11.02416515934]Search in Google Scholar
[12. Park JH, Choi KH, Lee HB, Rhee YK, Lee YC, Chung MJ. Intrathoracic malignant peripheral nerve sheath tumor in von Recklinghausen’s disease. Korean J Intern Med 2001; 16: 201-4.10.3904/kjim.2001.16.3.201453172911769579]Search in Google Scholar
[13. Chao BH, Stogner-Underwood KA, Kiev J, Smith TJ. Intrathoracic malignant peripheral nerve sheath tumor in neurofibromatosis 1. J Clin Oncol 2008; 26: 2216-8.10.1200/JCO.2007.14.675318445849]Search in Google Scholar
[14. Yamaguchi M, Yoshino I, Fukuyama S, Osoegawa A, Kameyama T, Tagawa T, et al. Surgical treatment of neurogenic tumors of the chest. Ann ThoracCardiovasc Surg 2004; 10: 148-51.]Search in Google Scholar
[15. Podobnik J, Kocijancic I, Kovac V, Sersa I. 3T MRI in evaluation of asbestosrelated thoracic diseases-preliminary results. Radiol Oncol 2012; 44: 92-6.]Search in Google Scholar
[16. Levy AD, Patel N, Dow N, Abbott RM, Miettinen M, Sobin LH. From the archives of the AFIP: abdominal neoplasms in patients with neurofibromatosis type 1: radiologic-pathologic correlation. Radiographics 2005; 25: 455-80.10.1148/rg.25204517615798063]Search in Google Scholar
[17. Murphey MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic- pathologic correlation. Radiographics 1999; 19: 1253-80.10.1148/radiographics.19.5.g99se10125310489179]Search in Google Scholar
[18. Li CS, Huang GS, Wu HD, Chen WT, Shih LS, Lii JM, et al. Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging. Clin Imaging 2008; 32: 121-7.10.1016/j.clinimag.2007.05.00618313576]Search in Google Scholar
[19. Bredella MA, Torriani M, Hornicek F, Ouellette HA, Plamer WE, Williams Z, et al. Value of PET in the assessment of patients with neurofibromatosis type 1. AJR Am J Roentgenol 2007; 189: 928-35.10.2214/AJR.07.206017885067]Search in Google Scholar
[20. Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H, et al. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol 2010; 194: 1568-74.10.2214/AJR.09.272420489098]Search in Google Scholar
[21. Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD. MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 1997; 27: 124-9.10.1007/s0024700500829028843]Search in Google Scholar
[22. Mautner VF, Asuagbor FA, Dombi E, Fünsterer C, Kluwe L, Wenzel R, et al. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol 2008; 10: 593-8.10.1215/15228517-2008-011266623318559970]Search in Google Scholar
[23. Van Meerbeeck SF, Verstraete KL, Janssens S, Mortier G. Whole body MR imaging in neurofibromatosis type 1. Eur J Radiol 2009; 69: 236-42.10.1016/j.ejrad.2008.10.02419091504]Search in Google Scholar